Update: Chinese Pharma Enlists Synaffix’s ADC Technology for Second Drug
Update (07/01/2020): Shanghai Miracogen has expanded its pre-existing license agreement with the Dutch biotech Synaffix.…
07/01/2020 - 2 minutes
Antibody-drug conjugates
Update: Swiss Biotech’s Series E Expanded to €271M to Commercialize Antibody-Guided Cancer Chemotherapy
Update (09/07/2019): The Switzerland-based ADC Therapeutics has completed the final closing of a €271M ($303M)…
09/07/2019 - 3 minutes
Mastering the Competitive World of Immuno-oncology
In recent years the oncology world has focused on using the immune system to target…
25/10/2018 - 5 minutes
Update: Yet Another ADC Company Makes Bank, This Time in Series B
Update (29.06.2018): NBE Therapeutics has extended its Series B fundraising round by 20M CHF (€17.3M),…
29/06/2018 - 3 minutes
New Antibody-Drug Conjugate Offers Hope to Hard-to-Treat Cancer Patients
ADC Therapeutics has tested its antibody-drug conjugate technology in drug-resistant cancers, yielding encouraging results. Swiss biotech…
11/12/2017 - 3 minutes
German Biotech Reels in €34M for its Cancer-Killing Technology
Heidelberg Pharma is developing Antibody Targeted Amanitin Conjugates (ATACs), which combine antibody-drug conjugate technology with the…
21/11/2017 - 1 minute
4th-Generation ADCs: Meet the Swiss Startup Perfecting the Technology
ADC development has progressed to the fourth generation. Serial entrepreneur Ulf Grawunder told me what…
04/10/2017 - 5 minutes
New UK Team will develop Next-Generation Antibody-Drug Conjugates for Cancer
Glythera and IONTAS have partnered to develop next-generation antibody-drug conjugates that are less toxic and more potent against difficult-to-treat…
20/09/2017 - 1 minute
Swiss ADCs Show Impressive Responses for Lymphoma in Phase I
ADC Therapeutics has presented preliminary Phase I data in lymphoma patients suggesting its ADC technology…
16/06/2017 - 2 minutes
Understand your Biologics: De-Risking the Biotech Pipeline
Characterizing biologics has become an essential step for successful drug development. We connected with SCIEX…
14/06/2017 - 5 minutes
Next-Gen Drug Conjugates Bank €46M in Series B with American Investors
Bicycle Therapeutics has closed a massive fundraising round, raking in £40M (€46M) from American investors to…
01/06/2017 - 3 minutes
What are the Current Challenges in the Booming Field of ADCs?
ADCs are overcoming the challenges of first generations and returning with a vengeance. I attended the…
24/02/2017 - 5 minutes
